Report of Foreign Issuer (6-k)
August 19 2020 - 7:01AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
of the Securities Exchange Act of 1934
For the Month of August 2020
Commission File Number 001-35948
Kamada Ltd.
(Translation of registrant’s name
into English)
2 Holzman Street
Science Park, P.O. Box 4081
Rehovot 7670402
Israel
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will
file annual reports under cover Form 20-F or Form 40-F.
Form 20-F
☒ Form 40-F ☐
Indicate by check mark if the registrant is submitting the Form
6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ____
Indicate by check mark if the registrant is submitting the Form
6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ____
Indicate by check mark whether the registrant by furnishing
the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b)
under the Securities Exchange Act of 1934.
Yes ☐
No ☒
If “Yes” is marked, indicate below the file number
assigned to the registrant in connection with Rule 12g3-2(b): 82-____
This Form 6-K is being
incorporated by reference into the Registrant's Form S-8 Registration Statements, File Nos. 333-192720, 333-207933,
333-215983, 333-222891 and 333-233267,
and the Registrant's Form F-3 Registration Statement, as amended, File No. 333-214816.
The following exhibit is attached:
99.1 Kamada and Kedrion Biopharma Announce
Results of First and Only U.S. Post-Marketing Pediatric Trial of a Human Rabies Immune Globulin (HRIG); The Study Met Its Primary
Objective
SIGNATURE
Pursuant to the requirements of the
Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
Date: August 19, 2020
|
KAMADA LTD.
|
|
|
|
|
By:
|
/s/ Orna Naveh
|
|
|
Orna Naveh
General Counsel and Corporate Secretary
|
EXHIBIT INDEX
3
Kamada (NASDAQ:KMDA)
Historical Stock Chart
From Mar 2024 to Apr 2024
Kamada (NASDAQ:KMDA)
Historical Stock Chart
From Apr 2023 to Apr 2024